Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital before delivery in pregnant women undergoing intrauterine transfusion
IRCT20201028049169N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2021
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of phenobarbital in anaemia and Erythroblastosis fetalis (HDFN) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Neonatal jaundice and phototherapy indication and Need for neonatal transfusion. Started Apr 2021; status: completed.
02
Drugs
phenobarbital
03
Conditions
anaemiaErythroblastosis fetalis (HDFN)
Beyond the preview
Go deeper on IRCT20201028049169N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049169N2.